Compare BOLD & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOLD | JG |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Computer Software: Programming Data Processing |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5M | 35.2M |
| IPO Year | 2024 | 2018 |
| Metric | BOLD | JG |
|---|---|---|
| Price | $1.42 | $5.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 69.5K | 2.9K |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.96 | $5.00 |
| 52 Week High | $1.68 | $12.74 |
| Indicator | BOLD | JG |
|---|---|---|
| Relative Strength Index (RSI) | 47.60 | 35.28 |
| Support Level | $1.40 | $5.00 |
| Resistance Level | $1.53 | $6.97 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 28.15 | 16.92 |
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates in one segment and generates revenues from SAAS Businesses.